IL DONG PHARMACEUTICAL CO., LTD. Logo

IL DONG PHARMACEUTICAL CO., LTD.

Develops & manufactures pharmaceuticals, APIs, and offers CMO services for various diseases.

249420 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
서울특별시 서초구 바우뫼로27길 2, 서초구
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

IL DONG PHARMACEUTICAL CO., LTD. is a healthcare company specializing in the research, development, manufacturing, and commercialization of pharmaceutical products. The company's business spans finished drugs, active pharmaceutical ingredients (APIs), and contract manufacturing (CMO) services, utilizing its GMP-certified facilities. Its therapeutic focus includes metabolic disorders, respiratory diseases, oncology, cardiovascular conditions, and gastrointestinal diseases. Ildong Pharmaceutical is committed to innovation, advancing a robust pipeline of novel drug candidates such as oral GLP-1 agonists for diabetes/obesity and first-in-class treatments for fibrotic diseases, partly through its spin-off iLeadBMS. The company is actively expanding its global market presence through strategic partnerships, licensing, and exports.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for IL DONG PHARMACEUTICAL CO., LTD. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-11 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 129.5 KB
2025-09-11 00:00
Major Shareholding Notification
최대주주등소유주식변동신고서
Korean 42.4 KB
2025-09-09 00:00
Report Publication Announcement
기업설명회(IR)개최(안내공시)
Korean 6.4 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 3.5 MB

Automate Your Workflow. Get a real-time feed of all IL DONG PHARMACEUTICAL CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for IL DONG PHARMACEUTICAL CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Psych Capital Plc Logo
A life sciences firm developing psilocybin treatments for anorexia and mental health conditions.
United Kingdom PSY
Pure Biologics S.A. Logo
Develops novel antibody & aptamer drugs for immuno-oncology and autoimmune diseases.
Poland PUR
Puretech Health PLC Logo
A clinical-stage biotherapeutics company developing new medicines for devastating diseases.
United States of America PRTC
PZ Cormay S.A. Logo
Manufactures and distributes IVD reagents and analyzers for human and veterinary medicine.
Poland CRM
Quantum Genomics Logo
Biopharma developing cardiovascular treatments, now in judicial liquidation.
France ALQGC
Quratis Inc. Logo
Develops infectious disease vaccines and offers biologics CDMO services for global health.
South Korea 348080
Recordati Industria Chimica e Farmaceutica Logo
Global pharma group developing drugs for common/rare diseases & supplying APIs worldwide.
Italy REC
Rekah Pharmaceutical Prod Ltd. Logo
A full-service generic pharma manufacturer of drugs, devices, and supplements for global markets.
Israel REKA
Replek AD Logo
Manufactures & distributes generic medicines, supplements, and cosmetic products to over 25 countries.
North Macedonia REPL
Respiratorius AB Logo
Develops oncology pre-treatment drugs to enhance the efficacy of standard cancer therapies.
Sweden RESP

Talk to a Data Expert

Have a question? We'll get back to you promptly.